Projects per year
Fingerprint The Fingerprint is created by mining the titles and abstracts of the person's research outputs and projects/funding awards to create an index of weighted terms from discipline-specific thesauri.
- 14 Similar Profiles
Endothelial Cells
Medicine & Life Sciences
Sickle Cell Anemia
Medicine & Life Sciences
Endothelium
Medicine & Life Sciences
Heme
Medicine & Life Sciences
Endothelial cells
Chemical Compounds
Heme Oxygenase-1
Medicine & Life Sciences
Oxidants
Medicine & Life Sciences
Iron
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects 1997 2022
Circulating Endothelial Cells and Microvesicles as Biomarkers for Gene Therapy in Sickle Cell Disease
Belcher, J. D., Beckman, J. D., Hebbel, R. P. & Vercellotti, G. M.
NIH Nat'l Heart, Lung, and Blood Inst.
9/20/19 → 2/17/20
Project: Research project
Sickle Cell Anemia
Genetic Therapy
Endothelial Cells
Biomarkers
Targeting mechanisms contributing to vascular dysfunction and pain in sickle cell disease
Gupta, K., Belcher, J. D., Guedes, A. & Vercellotti, G. M.
4/4/19 → 3/31/20
Project: Research project
Sickle Cell Anemia
Blood Vessels
Pain
Redefining clinical viscosity in sickle cell disease by leveraging microfluidic technologies
Wood, D. K., Datta, Y. H. & Vercellotti, G. M.
9/1/18 → 8/31/22
Project: Research project
Microfluidics
Sickle Cell Anemia
Viscosity
Technology
Mitobridge Study of HO-1 Induction in Sickle Cell Diseas
Belcher, J. D. & Vercellotti, G. M.
8/1/18 → 9/30/20
Project: Research project
Sickle Cell Anemia
training program
Research Output 1976 2019
A Simpler Answer – After All This Time
Coetzee, D. J., Vercellotti, G. M. & Olson, A. P., Feb 1 2019, In : American Journal of Medicine. 132, 2, p. e37-e38Research output: Contribution to journal › Article
3
Citations
(Scopus)
Critical role of C5a in sickle cell disease
Vercellotti, G. M., Dalmasso, A. P., Schaid, T. R., Nguyen, J., Chen, C., Ericson, M. E., Abdulla, F., Killeen, T., Lindorfer, M. A., Taylor, R. P. & Belcher, J. D., Mar 1 2019, In : American Journal of Hematology. 94, 3, p. 327-337 11 p.Research output: Contribution to journal › Article
Sickle Cell Anemia
Anaphylatoxin C5a Receptor
P-Selectin
Complement Activation
Immunoglobulin G
1
Citation
(Scopus)
First-in-human trial of rhIL-15 and haploidentical natural killer cell therapy for advanced acute myeloid leukemia
Cooley, S., He, F., Bachanova, V., Vercellotti, G. M., DeFor, T. E., Curtsinger, J. M., Robertson, P., Grzywacz, B., Conlon, K. C., Waldmann, T. A., McKenna, D. H., Blazar, B. R., Weisdorf, D. J. & Miller, J. S., Jan 1 2019, In : Blood Advances. 3, 13, p. 1970-1980 11 p.Research output: Contribution to journal › Article
Open Access
Interleukin-15
Cell- and Tissue-Based Therapy
Acute Myeloid Leukemia
Natural Killer Cells
Cytokines
Heme oxygenase-2 protects against ischemic acute kidney injury: influence of age and sex
Nath, K. A., Garovic, V. D., Grande, J. P., Croatt, A. J., Ackerman, A. W., Farrugia, G., Katusic, Z. S., Belcher, J. D. & Vercellotti, G. M., Sep 1 2019, In : American journal of physiology. Renal physiology. 317, 3, p. F695-F704Research output: Contribution to journal › Article
Acute Kidney Injury
Ischemia
Heme Oxygenase-1
Heme Oxygenase (Decyclizing)
Kidney
Intravenous immunoglobulin for treatment of necrobiotic xanthogranuloma
Goyal, A., O`Leary, D. H., Vercellotti, G. M., Miller, D. D. & Mc Glave, P. B., Jan 1 2019, In : Dermatologic Therapy. 32, 1, e12744.Research output: Contribution to journal › Letter
Necrobiotic Xanthogranuloma
Intravenous Immunoglobulins